Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001516440 | SCV001724720 | benign | Rubinstein-Taybi syndrome | 2023-11-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002502939 | SCV002807701 | likely benign | Rubinstein-Taybi syndrome due to CREBBP mutations; Menke-Hennekam syndrome 1 | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003903230 | SCV004726569 | likely benign | CREBBP-related disorder | 2021-05-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |